MAPT and Alzheimer disease: Comparable to Alzheimer’s disease (AD) in humans, CCD is associated with β-amyloid (Aβ) plaque accumulation, tau protein hyperphosphorylation, neuroinflammation, hippocampal atrophy, and gradual loss of cognitive function (2, 4, 5).